Patent 9339369 was granted and assigned to LifeCell Corporation on May, 2016 by the United States Patent and Trademark Office.
The present invention provides for an implantable medical device comprising a hybrid composite material including a first biological component such as an acellular tissue matrix and a second non-biological component for strengthening the device after implantation.